Animalcare Group PLC: Business Overview, Financials & Competitive Analysis
Animalcare Group PLC scores 5/10 on the AskCyborg Cyborg Score (Mixed). Specialized veterinary pharma player with defensive market dynamics but facing profitability headwinds requiring strategic repositioning. The company shows stable market position with growing revenue (~£74M estimated based on EBITDA metrics), but recent profitability pressures (net income down 100.87% in recent half-year) and modest market cap (£207M) indicate operational challenges.
What is Animalcare Group PLC's industry? Animalcare Group PLC (animalcaregroup.com) operates in Specialty Pharmaceuticals / Veterinary Medicines. AskCyborg classifies Animalcare Group PLC under Specialty Pharmaceuticals / Veterinary Medicines in its company registry.
Animalcare Group is a UK-based veterinary pharmaceutical company specializing in generic veterinary medicines and animal identification products for companion animals, production animals, and equine markets. The compa...
Cyborg Score thesis
Specialized veterinary pharma player with defensive market dynamics but facing profitability headwinds requiring strategic...
Read the full analyst-debate transcript →Get the Latest Animalcare Group PLC Report
Up-to-date AI-powered research, analyst debate audio & saved-company playlists
Get Current Report FreeAnimalcare Group PLC Overview
Pro stress-test →Animalcare Group is a UK-based veterinary pharmaceutical company specializing in generic veterinary medicines and animal identification products for companion animals, production animals, and equine markets. The company operates across multiple European territories with significant presence in Spain, serving veterinary professionals through a portfolio of licensed pharmaceutical solutions.
Strategic Profile
Pro stress-test →Positioned as a niche player in the specialty generic veterinary pharmaceuticals market, Animalcare leverages its established distribution network across Europe and investment in product innovation. The company is expanding its product pipeline through strategic collaborations, including a partnership with 272Bio Limited to develop novel biological treatments for equine conditions.
Competitive Landscape
Pro stress-test →Operates in fragmented European veterinary pharma market alongside larger generics manufacturers and branded veterinary pharmaceutical companies. Competitive advantages include established EU distribution networks and niche focus on companion animal treatments, though faces pressure from larger players with broader portfolios and cost advantages.
Industry Context
Animalcare Group PLC operates in Specialty Pharmaceuticals / Veterinary Medicines.
Key facts
Founded: 1972 · Headquarters: York, UK · Revenue: ~£74M · Market cap: £207M